ESC Premium Access

Discussant review: Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) trial: Primary Results

Topic: Primary cardiovascular prevention: interventions and outcomes

Congress Presentation

About the speaker

Professor Eugene Braunwald

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
33 presentations
5 followers

14 more presentations in this session

Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure, the RACE 3 study

Speaker: Professor I. Van Gelder (Groningen, NL)

Thumbnail

Discussant review: Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure, the RACE 3 study.

Speaker: Professor J. Brugada Terradellas (Barcelona, ES)

Thumbnail

Panel discussion.

Thumbnail

Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation: the CASTLE-AF trial

Speaker: Professor N. Marrouche (New Orleans, US)

Thumbnail

Discussant review: Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation: the CASTLE-AF trial

Speaker: Professor C. Blomstrom-Lundqvist (Orebro, SE)

Thumbnail

Access the full session

Hot Line: Late-Breaking Clinical Trials 1

Speakers: Professor E. Braunwald, Professor I. Van Gelder, Professor J. Brugada Terradellas, Professor N. Marrouche, Professor C. Blomstrom-Lundqvist
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk